The Joint Blog

FEBRUARY 24, 2021

For decades cannabis researchers have been investigating the impact cannabis has on neurological diseases. Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? had described some form of significant benefit from the treatment.

Treatment 55

Treatment Clinical Trials Collective Patients 55

Canna Care Docs

NOVEMBER 23, 2020

The 2020 election brought big wins for cannabis, with all of the five state ballot initiatives regarding legalization passing. Both adult-use (or recreational) and medicinal cannabis were legalized in South Dakota; Medicinal cannabis was approved in Mississippi; and adult-use initiatives passed in Arizona, Montana and New Jersey.

Legalization 52

Legalization Medicine Conditions Recreational 52

Veriheal

OCTOBER 1, 2020

All over the world, governments are moving towards legalizing or at least decriminalizing, cannabis. African, Asian, American, European, and other countries have all been following the global cannabis movement, whether for recreational or medicinal purposes. When we speak of the UK, think England, Scotland, Wales, and Northern Ireland.

Legalization 96

Legalization Oil Medicine Media 96

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Let’s explore this in more detail. What exactly is ALS?

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

NOVEMBER 24, 2021

Medical publications, are, in the main fairly positive toward cannabis. Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. At the same time, the outlook on cannabis research data is largely positive. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JULY 12, 2019

However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. Introduction: Recently, a formulation of cannabidiol was approved by the United States FDA.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

The Cannigma

OCTOBER 8, 2021

The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009.

Legalization 52

Legalization Medicine Conditions Patients 52